Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/24034Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Dousias, V. | en |
| dc.contributor.author | Stefos, T. | en |
| dc.contributor.author | Navrozoglou, I. | en |
| dc.contributor.author | Staikos, I. | en |
| dc.contributor.author | Ditto, A. | en |
| dc.contributor.author | Paraskevaidis, E. | en |
| dc.date.accessioned | 2015-11-24T19:37:28Z | - |
| dc.date.available | 2015-11-24T19:37:28Z | - |
| dc.identifier.issn | 0390-6663 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/24034 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Confidence Intervals | en |
| dc.subject | Dose-Response Relationship, Drug | en |
| dc.subject | Drug Administration Schedule | en |
| dc.subject | Erythropoietin/*administration & dosage | en |
| dc.subject | Female | en |
| dc.subject | Follow-Up Studies | en |
| dc.subject | Genital Neoplasms, Female/*drug therapy/mortality/pathology/*surgery | en |
| dc.subject | Gynecologic Surgical Procedures/*methods/mortality | en |
| dc.subject | Humans | en |
| dc.subject | Iron Compounds/*administration & dosage | en |
| dc.subject | Middle Aged | en |
| dc.subject | Neoplasm Staging | en |
| dc.subject | Preoperative Care | en |
| dc.subject | Probability | en |
| dc.subject | Prospective Studies | en |
| dc.subject | Recombinant Proteins | en |
| dc.subject | Reference Values | en |
| dc.subject | Risk Assessment | en |
| dc.subject | Survival Analysis | en |
| dc.subject | Treatment Outcome | en |
| dc.title | Administration of recombinant human erythropoietin in patients with gynecological cancer before radical surgery | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/16108399 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2005 | - |
| heal.abstract | The purpose of this prospective study was to investigate the efficacy of preoperative administration of recombinant human erythropoietin in patients with gynecological cancer. METHODS: The study included 38 women with gynecological cancer who were divided randomly in two groups. Study group A included 20 women with gynecological cancer who received recombinant human erythropoietin (rHuEPO) plus iron supplementation for ten days before surgery and five days postoperatively. Group B (controls) included 18 patients who received only iron supplementation for the same time period. Blood samples were obtained on days -10, -3, 0, +3, +5, +10. RESULTS: The mean hemoglobin level was significantly higher in group A than in group B on the day of the operation and remained significantly higher postoperatively while an inverse relationship was observed for mean ferritin values in the two groups. CONCLUSION: Preoperative administration of rHuEPO in patients with gynecological cancer seems to be effective in the blood management of these patients. | en |
| heal.journalName | Clin Exp Obstet Gynecol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
